LPAR2 and cancer: Taken together, the combination of OS, RFS, DFS and DMFS, and concern of bias, our findings illustrated the expression levels and prognostic value of LPAR2 in several types of cancers, especially HNSC and KIRC, suggesting that high LPAR2 expression plays significantly different prognostic roles in HNSC and KIRC.